Catalyst Pharmaceuticals, Inc. (DELISTED) (CPRX:DL)
31.49
0.00 (0.00%)
USD |
NASDAQ |
Jul 24, 16:00
Catalyst Pharmaceuticals Profit Margin (Quarterly) : 42.66% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 42.66% |
| December 31, 2025 | 34.53% |
| September 30, 2025 | 35.57% |
| June 30, 2025 | 35.55% |
| March 31, 2025 | 40.12% |
| December 31, 2024 | 39.44% |
| September 30, 2024 | 34.10% |
| June 30, 2024 | 33.24% |
| March 31, 2024 | 23.63% |
| December 31, 2023 | 31.51% |
| September 30, 2023 | -29.96% |
| June 30, 2023 | 37.92% |
| March 31, 2023 | 34.64% |
| December 31, 2022 | 41.92% |
| September 30, 2022 | 39.74% |
| Date | Value |
|---|---|
| June 30, 2022 | 40.70% |
| March 31, 2022 | 30.73% |
| December 31, 2021 | 24.30% |
| September 30, 2021 | 28.73% |
| June 30, 2021 | 33.50% |
| March 31, 2021 | 25.37% |
| December 31, 2020 | 36.88% |
| September 30, 2020 | |
| June 30, 2020 | 33.04% |
| March 31, 2020 | 35.78% |
| December 31, 2019 | 26.32% |
| September 30, 2019 | 44.11% |
| June 30, 2019 | 38.01% |
| March 31, 2019 | -5.18% |
| December 31, 2018 | -2.90K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -- |
| Indivior Pharmaceuticals, Inc. | 35.57% |
| Exelixis, Inc. | 33.73% |
| United Therapeutics Corp. | 42.51% |
| Krystal Biotech, Inc. | 45.94% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 24.39% |
| Return on Assets | 21.34% |
| Return on Invested Capital | 24.31% |
| Gross Profit Margin (Quarterly) | 83.82% |
| Operating Margin (Quarterly) | 49.02% |
| Return on Net Operating Assets | 78.37% |